<DOC>
	<DOCNO>NCT02248480</DOCNO>
	<brief_summary>The main purpose study evaluate efficacy study drug know duloxetine participant chronic osteoarthritis ( OA ) knee pain Japan .</brief_summary>
	<brief_title>A Study Duloxetine ( LY248686 ) Participants With Chronic Osteoarthritis Knee Pain Japan</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Participants present OA . Have pain ≥ 14 day month 3 month prior study entry . Participants must score ≥4 BPI average pain score randomization . Females childbearing potential must test negative ( ) pregnancy test . Participants appropriately complete daily diary . Have score change ≧3 BPI 24hour average pain score screen baseline . Participants serious cardiovascular , hepatic , renal , endocrine , respiratory , hematologic illness , peripheral vascular disease , medical condition neuropsychiatric condition clinically significant laboratory abnormality electrocardiographic abnormality . Participants alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) high 100 international unit per liter ( IU/L ) total bilirubin high 1.6 milligrams/deciliter ( mg/dL ) . Participants serum creatinine level high 2.0 mg/dL , renal transplantation receive renal dialysis . Participants diagnosis inflammatory arthritis ( , rheumatoid arthritis ) autoimmune disorder ( exclude inactive Hashimoto 's thyroiditis Type 1 diabetes ) . Participants previous diagnosis psychosis , bipolar disorder , schizoaffective disorder . Participants major depressive disorder determine use depression module MiniInternational Neuropsychiatric Interview ( M.I.N.I. ) . Participants uncorrected thyroid disease , uncontrolled narrowangle glaucoma , history uncontrolled seizure , uncontrolled poorly control hypertension . Participants receive intrarticular hyaluronate steroid , joint lavage , invasive therapy knee past 1 month . Participants knee arthroscopy index knee within past year joint replacement index knee osteotomy anytime . Participants endstage osteoarthritis surgery plan trial index joint . Participants prior synovial fluid analysis show white blood cell ( WBC ) ≥2000 cubic millimeter ( mm3 ) indicative diagnosis OA . Participants take excluded medication discontinue . Participants anticipated investigator require use nonsteroidal antiinflammatory drug include acetaminophen , opioid analgesic , exclude medication duration study . Participants treat monoamine oxidase inhibitor ( MAoI ) within 14 day prior baseline , potential need use MAO inhibitor study within 5 day discontinuation investigational drug . Participants answer 'yes ' question active suicidal ideation/intent/behaviors occur within past month ( ColumbiaSuicide Severity Rating Scale , suicide ideation sectionquestions 4 5 ; suicidal behavior section ) . Participants history one medical allergy . Are nonambulatory require use crutch walker . Have frequent fall could result hospitalization could compromise response treatment . Have primary painful condition may interfere assessment index joint , i.e. , knee . Have history drug abuse dependence within past year , include alcohol exclude nicotine caffeine . Have positive urine drug screen substance abuse exclude medication . Have receive administration another investigational drug within 30 day prior screen . Have previous exposure duloxetine completed/withdrawn study investigate duloxetine . Pregnant participant , female participant wish pregnant clinical study period , participant breastfeed ; male participant wish pregnancy partner .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>